How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses
- 15 December 2015
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 15 (3), 295-311
- https://doi.org/10.1586/14760584.2016.1128831
Abstract
Vaccines that protect against viral infections generally induce neutralizing antibodies. When vaccines are evaluated, the need arises to assess the affinity maturation of the antibody responses. Bi...Keywords
Funding Information
- National Institutes of Health (R37AI36082)
This publication has 118 references indexed in Scilit:
- Thirty years on: HIV receptor gymnastics and the prevention of infectionBMC Biology, 2013
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialThe New England Journal of Medicine, 2012
- Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitorsVirology, 2012
- HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and IncorporationJournal of Molecular Biology, 2011
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexesNature Medicine, 2011
- Evolving concepts of specificity in immune reactionsProceedings of the National Academy of Sciences of the United States of America, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandThe New England Journal of Medicine, 2009
- GM-CSF DNA: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccineVirology, 2007
- Antibody evolution constrains conformational heterogeneity by tailoring protein dynamicsProceedings of the National Academy of Sciences of the United States of America, 2006